tiprankstipranks
Trending News
More News >
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Balance Sheet

Compare
136 Followers

Sinovac Biotech Balance Sheet

Sinovac Biotech's total assets for Q1 2024 were $13.66B, a decrease of -0.49% from the previous quarter. SVA total liabilities were $1.64B for the fiscal quarter, a 9.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 13.66B$ 14.11B$ 16.75B$ 1.90B$ 452.30M
Total Liabilities
$ 1.64B$ 1.40B$ 2.87B$ 781.20M$ 100.10M
Total Equity Gross Minority
$ 12.02B$ 12.71B$ 13.88B$ 1.12B$ 352.19M
Other Metrics
Currency in USD

Sinovac Biotech Debt to Assets